Stern DF: Keeping Tumors Out of the MAPK Fitness Zone. Cancer Discov. 2018 Jan. PMID: 29311225

Theodosakis N, Micevic G, Langdon CG, Ventura A, Means R, Stern DF, Bosenberg MW: p90RSK Blockade Inhibits Dual BRAF and MEK Inhibitor-Resistant Melanoma by Targeting Protein Synthesis. J Invest Dermatol. 2017 Oct; 2017 Jun 7. PMID: 28599981

Klein MI, Stern DF, Zhao H: GRAPE: a pathway template method to characterize tissue-specific functionality from gene expression profiles. BMC Bioinformatics. 2017 Jun 26; 2017 Jun 26. PMID: 28651562

Langdon CG, Platt JT, Means RE, Iyidogan P, Mamillapalli R, Klein M, Held MA, Lee JW, Koo JS, Hatzis C, Hochster HS, Stern DF: Combinatorial Screening of Pancreatic Adenocarcinoma Reveals Sensitivity to Drug Combinations Including Bromodomain Inhibitor Plus Neddylation Inhibitor. Mol Cancer Ther. 2017 Jun; 2017 Mar 14. PMID: 28292938

Wali VB, Langdon CG, Held MA, Platt JT, Patwardhan GA, Safonov A, Aktas B, Pusztai L, Stern DF, Hatzis C: Systematic Drug Screening Identifies Tractable Targeted Combination Therapies in Triple-Negative Breast Cancer. Cancer Res. 2017 Jan 15; 2016 Nov 21. PMID: 27872098

Gayvert KM, Aly O, Platt J, Bosenberg MW, Stern DF, Elemento O: A Computational Approach for Identifying Synergistic Drug Combinations. PLoS Comput Biol. 2017 Jan; 2017 Jan 13. PMID: 28085880

Huang X, Stern DF, Zhao H: Transcriptional Profiles from Paired Normal Samples Offer Complementary Information on Cancer Patient Survival--Evidence from TCGA Pan-Cancer Data. Sci Rep. 2016 Feb 3; 2016 Feb 3. PMID: 26837275

Jeong J, VanHouten JN, Dann P, Kim W, Sullivan C, Yu H, Liotta L, Espina V, Stern DF, Friedman PA, Wysolmerski JJ: PMCA2 regulates HER2 protein kinase localization and signaling and promotes HER2-mediated breast cancer. Proc Natl Acad Sci U S A. 2016 Jan 19; 2016 Jan 4. PMID: 26729871

Langdon CG, Wiedemann N, Held MA, Mamillapalli R, Iyidogan P, Theodosakis N, Platt JT, Levy F, Vuagniaux G, Wang S, Bosenberg MW, Stern DF: SMAC mimetic Debio 1143 synergizes with taxanes, topoisomerase inhibitors and bromodomain inhibitors to impede growth of lung adenocarcinoma cells. Oncotarget. 2015 Nov 10. PMID: 26485762

Haskins JW, Zhang S, Means RE, Kelleher JK, Cline GW, Canfrán-Duque A, Suárez Y, Stern DF: Neuregulin-activated ERBB4 induces the SREBP-2 cholesterol biosynthetic pathway and increases low-density lipoprotein uptake. Sci Signal. 2015 Nov 3; 2015 Nov 3. PMID: 26535009

Theodosakis N, Held MA, Marzuka-Alcala A, Meeth KM, Micevic G, Long GV, Scolyer RA, Stern DF, Bosenberg MW: BRAF Inhibition Decreases Cellular Glucose Uptake in Melanoma in Association with Reduction in Cell Volume. Mol Cancer Ther. 2015 Jul; 2015 May 6. PMID: 25948295

Langdon CG, Held MA, Platt JT, Meeth K, Iyidogan P, Mamillapalli R, Koo AB, Klein M, Liu Z, Bosenberg MW, Stern DF: The broad-spectrum receptor tyrosine kinase inhibitor dovitinib suppresses growth of BRAF-mutant melanoma cells in combination with other signaling pathway inhibitors. Pigment Cell Melanoma Res. 2015 Jul; 2015 May 6. PMID: 25854919

Scortegagna M, Lau E, Zhang T, Feng Y, Sereduk C, Yin H, De SK, Meeth K, Platt JT, Langdon CG, Halaban R, Pellecchia M, Davies MA, Brown K, Stern DF, Bosenberg M, Ronai ZA: PDK1 and SGK3 Contribute to the Growth of BRAF-Mutant Melanomas and Are Potential Therapeutic Targets. Cancer Res. 2015 Apr 1; 2015 Feb 24. PMID: 25712345

Wali VB, Gilmore-Hebert M, Mamillapalli R, Haskins JW, Kurppa KJ, Elenius K, Booth CJ, Stern DF: Overexpression of ERBB4 JM-a CYT-1 and CYT-2 isoforms in transgenic mice reveals isoform-specific roles in mammary gland development and carcinogenesis. Breast Cancer Res. 2014 Dec 17; 2014 Dec 17. PMID: 25516216

Haskins JW, Nguyen DX, Stern DF: Neuregulin 1-activated ERBB4 interacts with YAP to induce Hippo pathway target genes and promote cell migration. Sci Signal. 2014 Dec 9; 2014 Dec 9. PMID: 25492965

Colavito SA, Zou MR, Yan Q, Nguyen DX, Stern DF: Significance of glioma-associated oncogene homolog 1 (GLI1) expression in claudin-low breast cancer and crosstalk with the nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB) pathway. Breast Cancer Res. 2014 Sep 25; 2014 Sep 25. PMID: 25252859

Hatzis C, Bedard PL, Birkbak NJ, Beck AH, Aerts HJ, Stem DF, Shi L, Clarke R, Quackenbush J, Haibe-Kains B: Enhancing reproducibility in cancer drug screening: how do we move forward? Cancer Res. 2014 Aug 1; 2014 Jul 11. PMID: 25015668

Wali VB, Haskins JW, Gilmore-Hebert M, Platt JT, Liu Z, Stern DF: Convergent and divergent cellular responses by ErbB4 isoforms in mammary epithelial cells. Mol Cancer Res. 2014 Aug; 2014 May 14. PMID: 24829397

Bai Y, Cheng H, Bordeaux J, Neumeister V, Kumar S, Rimm DL, Stern DF: Comparison of HER2 and phospho-HER2 expression between biopsy and resected breast cancer specimens using a quantitative assessment method. PLoS One. 2013; 2013 Nov 21. PMID: 24278211

Breindel JL, Haskins JW, Cowell EP, Zhao M, Nguyen DX, Stern DF: EGF receptor activates MET through MAPK to enhance non-small cell lung carcinoma invasion and brain metastasis. Cancer Res. 2013 Aug 15; 2013 Jun 21. PMID: 23794705

Tworkoski KA, Platt JT, Bacchiocchi A, Bosenberg M, Boggon TJ, Stern DF: MERTK controls melanoma cell migration and survival and differentially regulates cell behavior relative to AXL. Pigment Cell Melanoma Res. 2013 Jul; 2013 May 21. PMID: 23617806

Held MA, Langdon CG, Platt JT, Graham-Steed T, Liu Z, Chakraborty A, Bacchiocchi A, Koo A, Haskins JW, Bosenberg MW, Stern DF: Genotype-selective combination therapies for melanoma identified by high-throughput drug screening. Cancer Discov. 2013 Jan; 2012 Dec 13. PMID: 23239741

Krauthammer M, Kong Y, Ha BH, Evans P, Bacchiocchi A, McCusker JP, Cheng E, Davis MJ, Goh G, Choi M, Ariyan S, Narayan D, Dutton-Regester K, Capatana A, Holman EC, Bosenberg M, Sznol M, Kluger HM, Brash DE, Stern DF, Materin MA, Lo RS, Mane S, Ma S, Kidd KK, Hayward NK, Lifton RP, Schlessinger J, Boggon TJ, Halaban R: Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nat Genet. 2012 Sep; 2012 Jul 29. PMID: 22842228

Liu J, Luo S, Zhao H, Liao J, Li J, Yang C, Xu B, Stern DF, Xu X, Ye K: Structural mechanism of the phosphorylation-dependent dimerization of the MDC1 forkhead-associated domain. Nucleic Acids Res. 2012 May; 2012 Jan 10. PMID: 22234877

Wilson KA, Colavito SA, Schulz V, Wakefield PH, Sessa W, Tuck D, Stern DF: NFBD1/MDC1 regulates Cav1 and Cav2 independently of DNA damage and p53. Mol Cancer Res. 2011 Jun; 2011 May 6. PMID: 21551225

Tworkoski K, Singhal G, Szpakowski S, Zito CI, Bacchiocchi A, Muthusamy V, Bosenberg M, Krauthammer M, Halaban R, Stern DF: Phosphoproteomic screen identifies potential therapeutic targets in melanoma. Mol Cancer Res. 2011 Jun; 2011 Apr 26. PMID: 21521745

Stern DF: "Competence" progress. Mol Cell. 2011 May 20. PMID: 21596307

Stern DF: EGFs and ERBBs--brief history and prospects. Semin Cell Dev Biol. 2010 Dec; 2010 Oct 21. PMID: 20970513

Gilmore-Hebert M, Ramabhadran R, Stern DF: Interactions of ErbB4 and Kap1 connect the growth factor and DNA damage response pathways. Mol Cancer Res. 2010 Oct; 2010 Sep 21. PMID: 20858735

Golan A, Pick E, Tsvetkov L, Nadler Y, Kluger H, Stern DF: Centrosomal Chk2 in DNA damage responses and cell cycle progression. Cell Cycle. 2010 Jul 1. PMID: 20581449

Mok J, Kim PM, Lam HY, Piccirillo S, Zhou X, Jeschke GR, Sheridan DL, Parker SA, Desai V, Jwa M, Cameroni E, Niu H, Good M, Remenyi A, Ma JL, Sheu YJ, Sassi HE, Sopko R, Chan CS, De Virgilio C, Hollingsworth NM, Lim WA, Stern DF, Stillman B, Andrews BJ, Gerstein MB, Snyder M, Turk BE: Deciphering protein kinase specificity through large-scale analysis of yeast phosphorylation site motifs. Sci Signal. 2010 Feb 16; 2010 Feb 16. PMID: 20159853

Stern DF: BRCTing up is hard to do. Mol Cell. 2009 Jan 30. PMID: 19187753

Wilson KA, Stern DF: NFBD1/MDC1, 53BP1 and BRCA1 have both redundant and unique roles in the ATM pathway. Cell Cycle. 2008 Nov 15; 2008 Nov 29. PMID: 19001859

Zito CI, Riches D, Kolmakova J, Simons J, Egholm M, Stern DF: Direct resequencing of the complete ERBB2 coding sequence reveals an absence of activating mutations in ERBB2 amplified breast cancer. Genes Chromosomes Cancer. 2008 Jul. PMID: 18418848

Stern DF: ERBB3/HER3 and ERBB2/HER2 duet in mammary development and breast cancer. J Mammary Gland Biol Neoplasia. 2008 Jun; 2008 May 3. PMID: 18454306

DiGiovanna MP, Stern DF, Edgerton S, Broadwater G, Dressler LG, Budman DR, Henderson IC, Norton L, Liu ET, Muss HB, Berry DA, Hayes DF, Thor AD: Influence of activation state of ErbB-2 (HER-2) on response to adjuvant cyclophosphamide, doxorubicin, and fluorouracil for stage II, node-positive breast cancer: study 8541 from the Cancer and Leukemia Group B. J Clin Oncol. 2008 May 10; 2008 Apr 7. PMID: 18390970

Jia-Lin Ma N, Stern DF: Regulation of the Rad53 protein kinase in signal amplification by oligomer assembly and disassembly. Cell Cycle. 2008 Mar 15; 2008 Jan 8. PMID: 18239457

Jackson-Fisher AJ, Bellinger G, Breindel JL, Tavassoli FA, Booth CJ, Duong JK, Stern DF: ErbB3 is required for ductal morphogenesis in the mouse mammary gland. Breast Cancer Res. 2008; 2008 Nov 18. PMID: 19019207

Arbiser JL, Govindarajan B, Battle TE, Lynch R, Frank DA, Ushio-Fukai M, Perry BN, Stern DF, Bowden GT, Liu A, Klein E, Kolodziejski PJ, Eissa NT, Hossain CF, Nagle DG: Carbazole is a naturally occurring inhibitor of angiogenesis and inflammation isolated from antipsoriatic coal tar. J Invest Dermatol. 2006 Jun. PMID: 16614726

Ma JL, Lee SJ, Duong JK, Stern DF: Activation of the checkpoint kinase Rad53 by the phosphatidyl inositol kinase-like kinase Mec1. J Biol Chem. 2006 Feb 17; 2005 Dec 19. PMID: 16365046

Li J, Young CS, Lizardi PM, Stern DF: In situ detection of specific DNA double strand breaks using rolling circle amplification. Cell Cycle. 2005 Dec; 2005 Dec 27. PMID: 16294038

Ptacek J, Devgan G, Michaud G, Zhu H, Zhu X, Fasolo J, Guo H, Jona G, Breitkreutz A, Sopko R, McCartney RR, Schmidt MC, Rachidi N, Lee SJ, Mah AS, Meng L, Stark MJ, Stern DF, De Virgilio C, Tyers M, Andrews B, Gerstein M, Schweitzer B, Predki PF, Snyder M: Global analysis of protein phosphorylation in yeast. Nature. 2005 Dec 1. PMID: 16319894

Li J, Stern DF: DNA damage regulates Chk2 association with chromatin. J Biol Chem. 2005 Nov 11; 2005 Sep 8. PMID: 16150728

Amin DN, Tuck D, Stern DF: Neuregulin-regulated gene expression in mammary carcinoma cells. Exp Cell Res. 2005 Sep 10. PMID: 15963498

Stern DF: Phosphoproteomics for oncology discovery and treatment. Expert Opin Ther Targets. 2005 Aug. PMID: 16083347

Tsvetkov LM, Tsekova RT, Xu X, Stern DF: The Plk1 Polo box domain mediates a cell cycle and DNA damage regulated interaction with Chk2. Cell Cycle. 2005 Apr; 2005 Apr 9. PMID: 15876876

Li J, Stern DF: Regulation of CHK2 by DNA-dependent protein kinase. J Biol Chem. 2005 Mar 25; 2005 Jan 24. PMID: 15668230

Tsvetkov L, Stern DF: Interaction of chromatin-associated Plk1 and Mcm7. J Biol Chem. 2005 Mar 25; 2005 Jan 15. PMID: 15654075

DiGiovanna MP, Stern DF, Edgerton SM, Whalen SG, Moore D 2nd, Thor AD: Relationship of epidermal growth factor receptor expression to ErbB-2 signaling activity and prognosis in breast cancer patients. J Clin Oncol. 2005 Feb 20. PMID: 15718311

Modi S, DiGiovanna MP, Lu Z, Moskowitz C, Panageas KS, Van Poznak C, Hudis CA, Norton L, Tan L, Stern DF, Carter D, Seidman AD: Phosphorylated/activated HER2 as a marker of clinical resistance to single agent taxane chemotherapy for metastatic breast cancer. Cancer Invest. 2005. PMID: 16203655

Tsvetkov L, Stern DF: Phosphorylation of Plk1 at S137 and T210 is inhibited in response to DNA damage. Cell Cycle. 2005 Jan; 2005 Jan 5. PMID: 15611664

Jackson-Fisher AJ, Bellinger G, Ramabhadran R, Morris JK, Lee KF, Stern DF: ErbB2 is required for ductal morphogenesis of the mammary gland. Proc Natl Acad Sci U S A. 2004 Dec 7; 2004 Nov 29. PMID: 15569931

Lee SJ, Duong JK, Stern DF: A Ddc2-Rad53 fusion protein can bypass the requirements for RAD9 and MRC1 in Rad53 activation. Mol Biol Cell. 2004 Dec; 2004 Sep 29. PMID: 15456903

Stern DF: More than a marker... Phosphorylated Akt in prostate carcinoma. Clin Cancer Res. 2004 Oct 1. PMID: 15475426

Xu X, Lee J, Stern DF: Microcephalin is a DNA damage response protein involved in regulation of CHK1 and BRCA1. J Biol Chem. 2004 Aug 13; 2004 Jun 25. PMID: 15220350

Amin DN, Perkins AS, Stern DF: Gene expression profiling of ErbB receptor and ligand-dependent transcription. Oncogene. 2004 Feb 19. PMID: 14973552

Xu X, Stern DF: Establishment of a cell-free system to study the activation of Chk2. Methods Mol Biol. 2004. PMID: 15187252

Xu X, Stern DF: NFBD1/MDC1 regulates ionizing radiation-induced focus formation by DNA checkpoint signaling and repair factors. FASEB J. 2003 Oct. PMID: 14519663

Lee SJ, Schwartz MF, Duong JK, Stern DF: Rad53 phosphorylation site clusters are important for Rad53 regulation and signaling. Mol Cell Biol. 2003 Sep. PMID: 12917350

Tidcombe H, Jackson-Fisher A, Mathers K, Stern DF, Gassmann M, Golding JP: Neural and mammary gland defects in ErbB4 knockout mice genetically rescued from embryonic lethality. Proc Natl Acad Sci U S A. 2003 Jul 8; 2003 Jun 24. PMID: 12824469

Schwartz MF, Lee SJ, Duong JK, Eminaga S, Stern DF: FHA domain-mediated DNA checkpoint regulation of Rad53. Cell Cycle. 2003 Jul-Aug. PMID: 12851493

Stern DF: ErbBs in mammary development. Exp Cell Res. 2003 Mar 10. PMID: 12648468

Xu X, Stern DF: NFBD1/KIAA0170 is a chromatin-associated protein involved in DNA damage signaling pathways. J Biol Chem. 2003 Mar 7; 2002 Dec 23. PMID: 12499369

Tsvetkov L, Xu X, Li J, Stern DF: Polo-like kinase 1 and Chk2 interact and co-localize to centrosomes and the midbody. J Biol Chem. 2003 Mar 7; 2002 Dec 18. PMID: 12493754

DiGiovanna MP, Chu P, Davison TL, Howe CL, Carter D, Claus EB, Stern DF: Active signaling by HER-2/neu in a subpopulation of HER-2/neu-overexpressing ductal carcinoma in situ: clinicopathological correlates. Cancer Res. 2002 Nov 15. PMID: 12438265

Digiovanna MP, Stern DF, Roussel RR: Production of antibodies that recognize specific tyrosine-phosphorylated peptides. Curr Protoc Immunol. 2002 Nov. PMID: 18432869

Xu X, Tsvetkov LM, Stern DF: Chk2 activation and phosphorylation-dependent oligomerization. Mol Cell Biol. 2002 Jun. PMID: 12024051

Schwartz MF, Duong JK, Sun Z, Morrow JS, Pradhan D, Stern DF: Rad9 phosphorylation sites couple Rad53 to the Saccharomyces cerevisiae DNA damage checkpoint. Mol Cell. 2002 May. PMID: 12049741

DiGiovanna MP, Roussel RR, Stern DF: Production of antibodies that recognize specific tyrosine-phosphorylated peptides. Curr Protoc Cell Biol. 2002 Feb. PMID: 18228399